CA2527186A1 - Methodes et compositions contenant des composes de gastrine - Google Patents
Methodes et compositions contenant des composes de gastrine Download PDFInfo
- Publication number
- CA2527186A1 CA2527186A1 CA002527186A CA2527186A CA2527186A1 CA 2527186 A1 CA2527186 A1 CA 2527186A1 CA 002527186 A CA002527186 A CA 002527186A CA 2527186 A CA2527186 A CA 2527186A CA 2527186 A1 CA2527186 A1 CA 2527186A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- weeks
- cells
- gastrin compound
- gastrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
USPCT/US03/16660 | 2003-05-27 | ||
PCT/US2003/016660 WO2003100024A2 (fr) | 2002-05-24 | 2003-05-27 | Traitement du diabete |
PCT/CA2004/000769 WO2004105780A2 (fr) | 2003-05-27 | 2004-05-27 | Methodes et compositions contenant des composes de gastrine |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2527186A1 true CA2527186A1 (fr) | 2004-12-09 |
Family
ID=33488788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002527186A Abandoned CA2527186A1 (fr) | 2003-05-27 | 2004-05-27 | Methodes et compositions contenant des composes de gastrine |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1648495A2 (fr) |
JP (1) | JP2007513059A (fr) |
CN (1) | CN1829528A (fr) |
AU (1) | AU2004243541A1 (fr) |
BR (1) | BRPI0410710A (fr) |
CA (1) | CA2527186A1 (fr) |
MX (1) | MXPA05012605A (fr) |
NO (1) | NO20055582L (fr) |
PL (1) | PL379145A1 (fr) |
RU (1) | RU2005140518A (fr) |
WO (1) | WO2004105780A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1486204A (zh) | 2001-01-12 | 2004-03-31 | ������˹ҩƷ��˾ | 用于胰岛再生的含胃泌素/cck受体配基及egf受体配基的组合物 |
EP1837031B1 (fr) | 2002-06-07 | 2009-10-14 | Waratah Pharmaceuticals, Inc. | Methodes et compositions pour le traitement du diabete |
ES2334268T3 (es) | 2002-06-07 | 2010-03-08 | Waratah Pharmaceuticals, Inc. | Procedimientos y composiciones para el tratamiento de la diabetes. |
BRPI0507189A (pt) * | 2004-01-30 | 2007-06-26 | Waratah Pharmaceuticals Inc | uso combinado de um agonista de glp-1 e compostos de gastrina |
US20100256061A1 (en) * | 2007-03-02 | 2010-10-07 | Antonio Cruz | Gastrin compound for diabetes treatment |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6558952B1 (en) * | 1992-12-14 | 2003-05-06 | Waratah Pharmaceuticals, Inc. | Treatment for diabetes |
ES2185663T3 (es) * | 1994-01-24 | 2003-05-01 | Waratah Pharmaceuticals Inc | Tratamiento de la diabetes. |
CN1486204A (zh) * | 2001-01-12 | 2004-03-31 | ������˹ҩƷ��˾ | 用于胰岛再生的含胃泌素/cck受体配基及egf受体配基的组合物 |
DE60326002D1 (de) * | 2002-10-22 | 2009-03-12 | Waratah Pharmaceuticals Inc | Behandlung von diabetes. |
-
2004
- 2004-05-27 AU AU2004243541A patent/AU2004243541A1/en not_active Withdrawn
- 2004-05-27 CN CNA200480022042XA patent/CN1829528A/zh active Pending
- 2004-05-27 BR BRPI0410710-1A patent/BRPI0410710A/pt not_active IP Right Cessation
- 2004-05-27 PL PL379145A patent/PL379145A1/pl not_active Application Discontinuation
- 2004-05-27 CA CA002527186A patent/CA2527186A1/fr not_active Abandoned
- 2004-05-27 WO PCT/CA2004/000769 patent/WO2004105780A2/fr active Application Filing
- 2004-05-27 RU RU2005140518/15A patent/RU2005140518A/ru not_active Application Discontinuation
- 2004-05-27 JP JP2006529497A patent/JP2007513059A/ja active Pending
- 2004-05-27 EP EP04737749A patent/EP1648495A2/fr not_active Withdrawn
- 2004-05-27 MX MXPA05012605A patent/MXPA05012605A/es not_active Application Discontinuation
-
2005
- 2005-11-25 NO NO20055582A patent/NO20055582L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1648495A2 (fr) | 2006-04-26 |
BRPI0410710A (pt) | 2006-06-13 |
RU2005140518A (ru) | 2007-07-10 |
WO2004105780A3 (fr) | 2005-01-20 |
JP2007513059A (ja) | 2007-05-24 |
NO20055582L (no) | 2006-02-27 |
NO20055582D0 (no) | 2005-11-25 |
WO2004105780A2 (fr) | 2004-12-09 |
PL379145A1 (pl) | 2006-07-24 |
CN1829528A (zh) | 2006-09-06 |
AU2004243541A1 (en) | 2004-12-09 |
MXPA05012605A (es) | 2006-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005207870B2 (en) | The combined use of GLP-1 agonists and gastrin for regulating blood glucose levels | |
KR100365606B1 (ko) | 수술후 이화작용 변화를 제거하기 위한 글루카곤-유사 펩타이드-1 (glp-1) 또는 동족체를 포함하는 약제학적 조성물 | |
ES2949553T3 (es) | Composición para el tratamiento de la diabetes, que contiene conjugado de análogo de insulina de acción prolongada y conjugado de péptido de secreción de insulina de acción prolongada | |
US20140364362A1 (en) | Therapeutic agents comprising insulin amino acid sequences | |
US20090117102A1 (en) | Methods and compositions using CD3 agonists | |
EP2186824A2 (fr) | Posologie de traitement chronique à l'aide de peptides insulinotropiques de type glucagon | |
UA65549C2 (uk) | Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція | |
US8222217B2 (en) | Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders | |
AU2002239384A1 (en) | Chronic treatment regimen using glucagon-like insulinotropic peptides | |
CA2452044A1 (fr) | Pre-melanges de polypeptide glp-1 et d'insuline basale | |
US20150361154A1 (en) | Therapeutic agents, compositions, and methods for glycemic control | |
CN102421796A (zh) | 新型Exendin变体及其缀合物 | |
CZ299059B6 (cs) | Použití GLP-1 nebo jeho analogu pro lécbu infarktu myokardu | |
WO2007095737A1 (fr) | Polythérapie pour le traitement du diabète, comprenant un agoniste d'exendine et un composé de gastrine | |
US20090156494A1 (en) | Compositions and methods comprising gastrin compounds | |
EP1620464A1 (fr) | Utilisation combinee d'agonistes de facteur de croissance de keratinocytes et de composes de gastrine | |
CA2527186A1 (fr) | Methodes et compositions contenant des composes de gastrine | |
US20100256061A1 (en) | Gastrin compound for diabetes treatment | |
KR20060017617A (ko) | 가스트린 화합물을 포함하는 조성물 및 이의 용도 | |
TW201441253A (zh) | 具有n端電荷修飾之促胰島素肽衍生物 | |
MXPA06008394A (en) | The combined use of glp-1 agonists and gastrin for regulating blood glucose levels | |
MXPA01003008A (es) | Uso de peptido similar a glucagon 1 (glp-1) o analogos en el tratamiento de la crisis fulminante | |
MXPA99001871A (en) | Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery | |
PL191627B1 (pl) | Zastosowanie peptydu GLP-1 do wytwarzania leku do leczniczego zmniejszania masy ciała u człowieka |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20100527 |